|
Index | - | P/E | - | EPS (ttm) | -0.12 | Insider Own | 5.01% | Shs Outstand | 99.53M | Perf Week | 3.36% |
Market Cap | 155.27M | Forward P/E | - | EPS next Y | - | Insider Trans | 0.00% | Shs Float | 94.94M | Perf Month | -6.59% |
Income | - | PEG | - | EPS next Q | - | Inst Own | 0.85% | Short Float / Ratio | 0.01% / 0.48 | Perf Quarter | -3.11% |
Sales | 0.22M | P/S | 690.34 | EPS this Y | - | Inst Trans | - | Short Interest | 0.01M | Perf Half Y | -18.32% |
Book/sh | 0.26 | P/B | 6.00 | EPS next Y | - | ROA | - | Target Price | - | Perf Year | -39.06% |
Cash/sh | - | P/C | - | EPS next 5Y | - | ROE | - | 52W Range | 1.28 - 3.78 | Perf YTD | 0.65% |
Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | - | 52W High | -58.73% | Beta | - |
Dividend % | - | Quick Ratio | - | Sales past 5Y | - | Gross Margin | - | 52W Low | 21.87% | ATR | 0.10 |
Employees | - | Current Ratio | - | Sales Q/Q | -57.10% | Oper. Margin | - | RSI (14) | 50.44 | Volatility | 7.28% 7.24% |
Optionable | No | Debt/Eq | - | EPS Q/Q | - | Profit Margin | - | Rel Volume | 3.44 | Prev Close | 1.56 |
Shortable | Yes | LT Debt/Eq | - | Earnings | - | Payout | - | Avg Volume | 25.97K | Price | 1.56 |
Recom | - | SMA20 | -0.04% | SMA50 | 1.42% | SMA200 | -10.71% | Volume | 22,514 | Change | 0.00% |
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite